Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13562)
All Articles published online
|
Publishing Process of This Article
|
Feb 21, 2014 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Schwenger KJ, Allard JP. Clinical approaches to non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(7): 1712-1723 [PMID: 24587650 DOI: 10.3748/wjg.v20.i7.1712] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i7/1712.htm |
| Number | Citing Articles |
| 1 |
Takako Mukai, Miki Egawa, Tamaki Takeuchi, Hitoshi Yamashita, Tatsuya Kusudo. Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease. FEBS Open Bio 2017; 7(7): 1009 doi: 10.1002/2211-5463.12240
|
| 2 |
Farah Ahsan, Federico Oliveri, Harshit K Goud, Zainab Mehkari, Lubna Mohammed, Moiz Javed, Aldanah Althwanay, Ian H Rutkofsky. Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Cureus 2020; doi: 10.7759/cureus.10446
|
| 3 |
Loek P. Smits, Bram F. Coolen, Maria D. Panno, Jurgen H. Runge, Wouter H. Nijhof, Joanne Verheij, Max Nieuwdorp, Jaap Stoker, Ulrich H. Beuers, Aart J. Nederveen, Erik S. Stroes. Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study. Radiology 2016; 278(3): 782 doi: 10.1148/radiol.2015150952
|
| 4 |
Mahardian Rahmadi, Ahmad Dzulfikri Nurhan, Eka Dewi Pratiwi, Devita Ardina Prameswari, Sisca Melani Panggono, Khoirotin Nisak, Junaidi Khotib. The effect of various high-fat diet on liver histology in the development of NAFLD models in mice. Journal of Basic and Clinical Physiology and Pharmacology 2021; 32(4): 547 doi: 10.1515/jbcpp-2020-0426
|
| 5 |
Yumeng Liu, Yiming Liu, Delun Mu, Hui Yang, Ying Feng, Ruiqin Ji, Rina Wu, Junrui Wu. Preparation, structural characterization and bioactivities of polysaccharides from mulberry (Mori Fructus). Food Bioscience 2022; 46: 101604 doi: 10.1016/j.fbio.2022.101604
|
| 6 |
Qian Zhang, Yatian Jia, Yuexing Zhang, Yan Wang, Xinru Li, Xiaoying Tian, Shifan Han. The effects of medicinal and food homologous substances on blood lipid and blood glucose levels and liver function in patients with nonalcoholic fatty liver disease: a systematic review of randomized controlled trials. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01900-5
|
| 7 |
Leila Gobejishvili, Smita Ghare, Rehan Khan, Alexander Cambon, David F. Barker, Shirish Barve, Craig McClain, Daniell Hill. Misoprostol modulates cytokine expression through a cAMP pathway: Potential therapeutic implication for liver disease. Clinical Immunology 2015; 161(2): 291 doi: 10.1016/j.clim.2015.09.008
|
| 8 |
Kazuki Moro, Masayuki Nagahashi, Rajesh Ramanathan, Kazuaki Takabe, Toshifumi Wakai. Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer. World Journal of Clinical Cases 2016; 4(7): 155-164 doi: 10.12998/wjcc.v4.i7.155
|
| 9 |
A. Sadykova, M. Kadyrberdieva, A. Mamatalieva, Zh. Abdullaeva. Fatty Liver Degeneration in Cardiovascular Diseases. Bulletin of Science and Practice 2021; 7(11): 195 doi: 10.33619/2414-2948/72/24
|
| 10 |
Jian Li, Zezhou Liu, Mingxing Guo, Kejia Xu, Miao Jiang, Aiping Lu, Xiaoyan Gao. Metabolomics Profiling to Investigate the Pharmacologic Mechanisms of Berberine for the Treatment of High-Fat Diet-Induced Nonalcoholic Steatohepatitis. Evidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/897914
|
| 11 |
Abdo Mahli, Tatjana Seitz, Kim Freese, Jan Frank, Ralf Weiskirchen, Mona Abdel-Tawab, Dariush Behnam, Claus Hellerbrand. Therapeutic Application of Micellar Solubilized Xanthohumol in a Western-Type Diet-Induced Mouse Model of Obesity, Diabetes and Non-Alcoholic Fatty Liver Disease. Cells 2019; 8(4): 359 doi: 10.3390/cells8040359
|
| 12 |
Virginia Pardo, Águeda González-Rodríguez, Carlos Guijas, Jesús Balsinde, Ángela M. Valverde. Opposite Cross-Talk by Oleate and Palmitate on Insulin Signaling in Hepatocytes through Macrophage Activation. Journal of Biological Chemistry 2015; 290(18): 11663 doi: 10.1074/jbc.M115.649483
|
| 13 |
Xianwen Yuan, Jun Chen, Qi Cheng, Yinjuan Zhao, Pengzi Zhang, Xiaoyan Shao, Yan Bi, Xiaolei Shi, Yitao Ding, Xitai Sun, Bin Xue. Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0871-2
|
| 14 |
A A Svistunov, M A Osadchuk, L I Butorova, G M Tokmulina. Chronic constipation in the practice of a therapist: Features of therapy for comorbidity. Terapevticheskii arkhiv 2017; 89(4): 69 doi: 10.17116/terarkh201789469-74
|
| 15 |
Katherine J.P. Schwenger, Sandra E. Fischer, Timothy Jackson, Allan Okrainec, Johane P. Allard. In nonalcoholic fatty liver disease, Roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic control. Surgery for Obesity and Related Diseases 2018; 14(9): 1233 doi: 10.1016/j.soard.2018.06.007
|
| 16 |
Amanda Chaney. Treating the patient with nonalcoholic fatty liver disease. The Nurse Practitioner 2015; 40(11): 36 doi: 10.1097/01.NPR.0000472248.28703.18
|
| 17 |
Yu Seol Lee, Jeong Su Park, Da Hyun Lee, Dong-Kyu Lee, Sung Won Kwon, Byung-Wan Lee, Soo Han Bae. The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 Inhibition. Frontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00539
|
| 18 |
Gavin Hamilton, Michael S. Middleton, Elhamy R. Heba, Claude B. Sirlin. Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development. 2015; : 99 doi: 10.1007/978-1-4471-4920-0_4
|
| 19 |
Olfat M. Hendy, Maha M. Elsabaawy, Mona M. Aref, Fatma M. Khalaf, Abdel Moaty A. Oda, Helmy M. El Shazly. Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver disease. APMIS 2017; 125(7): 607 doi: 10.1111/apm.12696
|
| 20 |
Shu Dong, Zong-Ying Zhan, Hong-Yan Cao, Chao Wu, Yan-Qin Bian, Jian-Yuan Li, Gen-Hong Cheng, Ping Liu, Ming-Yu Sun. Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(15): 2771-2784 doi: 10.3748/wjg.v23.i15.2771
|
| 21 |
Katherine T. Brunner, Cameron J. Henneberg, Robert M. Wilechansky, Michelle T. Long. Nonalcoholic Fatty Liver Disease and Obesity Treatment. Current Obesity Reports 2019; 8(3): 220 doi: 10.1007/s13679-019-00345-1
|
| 22 |
Yukio Osaki, Hiroki Nishikawa. Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review. Hepatology Research 2015; 45(1): 59 doi: 10.1111/hepr.12378
|
| 23 |
Shuntarou Tsuchiya, Yuichiro Amano, Osamu Isono, Mayumi Imai, Fumi Shimizu, Mari Asada, Shigemitsu Imai, Ayako Harada, Yoshitaka Yasuhara, Ryuichi Tozawa, Hiroshi Nagabukuro. Pharmacological evaluation of pioglitazone and candesartan cilexetil in a novel mouse model of non‐alcoholic steatohepatitis, modified choline‐deficient, amino acid‐defined diet fed low‐density lipoprotein receptor knockout mice. Hepatology Research 2017; 47(6): 584 doi: 10.1111/hepr.12773
|
| 24 |
Peter Dietrich, Claus Hellerbrand. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Practice & Research Clinical Gastroenterology 2014; 28(4): 637 doi: 10.1016/j.bpg.2014.07.008
|
| 25 |
Mohammad Rashidmayvan, Majid Mohammadshahi, Seyed Saeed Seyedian, Mohammad Hossein Haghighizadeh. The effect of Nigella sativa oil on serum levels of inflammatory markers, liver enzymes, lipid profile, insulin and fasting blood sugar in patients with non-alcoholic fatty liver. Journal of Diabetes & Metabolic Disorders 2019; 18(2): 453 doi: 10.1007/s40200-019-00439-6
|
| 26 |
Md. Murad Hossain, Abdul Mukheem, Tunku Kamarul. The prevention and treatment of hypoadiponectinemia-associated human diseases by up-regulation of plasma adiponectin. Life Sciences 2015; 135: 55 doi: 10.1016/j.lfs.2015.03.010
|
| 27 |
Dina L. Halegoua-De Marzio, Jonathan M. Fenkel. Concepts and Treatment Approaches in Nonalcoholic Fatty Liver Disease. Advances in Hepatology 2014; 2014: 1 doi: 10.1155/2014/357965
|
| 28 |
Da Zhou, Qin Pan, Xiao‐Lin Liu, Rui‐Xu Yang, Yuan‐Wen Chen, Chang Liu, Jian‐Gao Fan. Clostridium butyricum B1 alleviates high‐fat diet‐induced steatohepatitis in mice via enterohepatic immunoregulation. Journal of Gastroenterology and Hepatology 2017; 32(9): 1640 doi: 10.1111/jgh.13742
|
| 29 |
Roya Navekar, Maryam Rafraf, Aida Ghaffari, Mohammad Asghari-Jafarabadi, Manouchehr Khoshbaten. Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases. Journal of the American College of Nutrition 2017; 36(4): 261 doi: 10.1080/07315724.2016.1267597
|
| 30 |
Iria Cebreiros López, José Antonio Noguera Velasco. Valoración de la enfermedad por hígado graso no alcohólico desde el laboratorio clínico. Revista del Laboratorio Clínico 2018; 11(3): 163 doi: 10.1016/j.labcli.2017.10.004
|
| 31 |
Montserrat Marí, Albert Morales, Anna Colell, Carmen García-Ruiz, José C. Fernandez-Checa. Studies on Hepatic Disorders. Oxidative Stress in Applied Basic Research and Clinical Practice 2015; : 279 doi: 10.1007/978-3-319-15539-5_12
|
| 32 |
Qian Li, Steven W. Blume, Joanna C. Huang, Mette Hammer, Michael L. Ganz. Prevalence and healthcare costs of obesity-related comorbidities: evidence from an electronic medical records system in the United States. Journal of Medical Economics 2015; 18(12): 1020 doi: 10.3111/13696998.2015.1067623
|
| 33 |
Rafael Deminice, Gabriela S. de Castro, Margaret E. Brosnan, John T. Brosnan. Creatine supplementation as a possible new therapeutic approach for fatty liver disease: early findings. Amino Acids 2016; 48(8): 1983 doi: 10.1007/s00726-016-2183-6
|
| 34 |
Parisa Shabani, H Naeimi Khaledi, Maani Beigy, Solaleh Emamgholipour, Eskandar Parvaz, Hossein Poustchi, Mahmood Doosti, Manlio Vinciguerra. Circulating Level of CTRP1 in Patients with Nonalcoholic Fatty Liver Disease (NAFLD): Is It through Insulin Resistance?. PLOS ONE 2015; 10(3): e0118650 doi: 10.1371/journal.pone.0118650
|
| 35 |
Shehab M Abd El-Kader, Eman M Salah El-Den Ashmawy. Non-alcoholic fatty liver disease: The diagnosis and management. World Journal of Hepatology 2015; 7(6): 846-858 doi: 10.4254/wjh.v7.i6.846
|
| 36 |
Lihi Grinberg, Fadwa Dabbah Assadi, Gideon Baum, Romy Zemel, Ran Tur-Kaspa, Chen Shochat, David Karasik, Marcela V. Karpuj. Beneficial Effect of Vitamin D on Non-Alcoholic Fatty Liver Disease (NAFLD) Progression in the Zebrafish Model. Nutrients 2023; 15(6): 1362 doi: 10.3390/nu15061362
|
| 37 |
Adnan Malik, Muhammad Malik. Effects of curcumin in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. Canadian Liver Journal 2024; 7(2): 299 doi: 10.3138/canlivj-2023-0022
|
| 38 |
Fred F. Poordad. Presentation and complications associated with cirrhosis of the liver. Current Medical Research and Opinion 2015; 31(5): 925 doi: 10.1185/03007995.2015.1021905
|
| 39 |
C. Bertrand, P. Valet, I. Castan-Laurell. Stéatose et résistance à l’insuline : implication des hépatokines. Obésité 2016; 11(3): 170 doi: 10.1007/s11690-015-0492-7
|
| 40 |
Deanna M Salter, Wei Wei, Pragati P Nahar, Emily Marques, Angela L Slitt. Perfluorooctanesulfonic Acid (PFOS) Thwarts the Beneficial Effects of Calorie Restriction and Metformin. Toxicological Sciences 2021; 182(1): 82 doi: 10.1093/toxsci/kfab043
|
| 41 |
Fabiana de Faria Ghetti, Daiane Gonçalves Oliveira, Juliano Machado de Oliveira, Lincoln Eduardo Villela Vieira de Castro Ferreira, Dionéia Evangelista Cesar, Ana Paula Boroni Moreira. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis. European Journal of Nutrition 2018; 57(3): 861 doi: 10.1007/s00394-017-1524-x
|
| 42 |
Raquel S. Torrinhas, Dan L. Waitzberg. A Double-blinded Randomized Placebo-controlled Clinical Trial of Omega-3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis. Journal of Clinical Gastroenterology 2016; 50(2): 180 doi: 10.1097/MCG.0000000000000412
|
| 43 |
Giada Sebastiani, Rasha Alshaalan, Philip Wong, Maria Rubino, Ayat Salman, Peter Metrakos, Marc Deschenes, Peter Ghali, Han-Chieh Lin. Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis. PLOS ONE 2015; 10(6): e0128774 doi: 10.1371/journal.pone.0128774
|
| 44 |
Giovanni Brandi, Stefania De Lorenzo, Stefania Di Girolamo, Stefano Bellentani, Gioconda Saccoccio, Guido Biasco. Fulminant Hepatitis in a Patient with Hepatocellular Carcinoma Related to Nonalcoholic Steatohepatitis Treated with Sorafenib. Tumori Journal 2015; 101(2): e46 doi: 10.5301/tj.5000247
|
| 45 |
Emanuele Rinninella, Maria Cristina Mele, Nicolò Merendino, Marco Cintoni, Gaia Anselmi, Aldo Caporossi, Antonio Gasbarrini, Angelo Maria Minnella. The Role of Diet, Micronutrients and the Gut Microbiota in Age-Related Macular Degeneration: New Perspectives from the Gut–Retina Axis. Nutrients 2018; 10(11): 1677 doi: 10.3390/nu10111677
|
| 46 |
Farnaz Farsi, Majid Mohammadshahi, Pezhman Alavinejad, Afshin Rezazadeh, Mehdi Zarei, Kambiz Ahmadi Engali. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Journal of the American College of Nutrition 2016; 35(4): 346 doi: 10.1080/07315724.2015.1021057
|
| 47 |
Andrey Turchinovich, Ancha Baranova, Oksana Drapkina, Alexander Tonevitsky. Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders. Frontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.01256
|
| 48 |
Ainara Cano, Cristina Alonso. Deciphering non-alcoholic fatty liver disease through metabolomics. Biochemical Society Transactions 2014; 42(5): 1447 doi: 10.1042/BST20140138
|
| 49 |
Qiaoli Tang, Shan Jiang, Wenjun Jia, Di Shen, Yudong Qiu, Yue Zhao, Bin Xue, Chaojun Li. Zoledronic acid, an FPPS inhibitor, ameliorates liver steatosis through inhibiting hepatic de novo lipogenesis. European Journal of Pharmacology 2017; 814: 169 doi: 10.1016/j.ejphar.2017.08.010
|
| 50 |
Amirhossein Sahebkar, Gerard T. Chew, Gerald F. Watts. Recent advances in pharmacotherapy for hypertriglyceridemia. Progress in Lipid Research 2014; 56: 47 doi: 10.1016/j.plipres.2014.07.002
|
| 51 |
Shinhiti Morita, Dalísio De Santi Neto, Flávio Hiroshi Ananias Morita, Nina Kimie Morita, Suzana Margareth Ajeje Lobo. Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery. Obesity Surgery 2015; 25(12): 2335 doi: 10.1007/s11695-015-1696-5
|
| 52 |
Azza S. M. Awad, Ekram N. Abd Al Haleem, Wesam M. El-Bakly, Mohie A. Sherief. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. Naunyn-Schmiedeberg's Archives of Pharmacology 2016; 389(4): 381 doi: 10.1007/s00210-015-1207-1
|
| 53 |
Chih‐Lin Lin, Chi‐Ming Tai, Jee‐Fu Huang, Chun‐Jen Liu, Hui‐Fen Chen, Pin‐Nan Cheng, Chi‐Yi Chen, Cheng‐Yuan Peng, Chia‐Chi Wang, Shih‐Han Weng, Tai‐Chung Tseng, Jia‐Horng Kao. The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan. Journal of Gastroenterology and Hepatology 2022; 37(10): 1901 doi: 10.1111/jgh.15936
|
| 54 |
Biyu Hou, Yuerong Zhao, Guifen Qiang, Xiuying Yang, Chunyang Xu, Xi Chen, Chenge Liu, Xiaobo Wang, Li Zhang, Guanhua Du, Giuseppe Valacchi. Puerarin Mitigates Diabetic Hepatic Steatosis and Fibrosis by Inhibiting TGF‐β Signaling Pathway Activation in Type 2 Diabetic Rats. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/4545321
|
| 55 |
Swaytha Ganesh, Vinod K. Rustgi. Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2016; 20(2): 351 doi: 10.1016/j.cld.2015.10.009
|
| 56 |
Wen-Pei Chang, Yu-Pei Chang. Correlation between Component Factors of Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome in Nurses: An Observational and Cross-Sectional Study. International Journal of Environmental Research and Public Health 2022; 19(23): 16294 doi: 10.3390/ijerph192316294
|
| 57 |
Andrew Jenkinson. Clinical Dilemmas in Non‐Alcoholic Fatty Liver Disease. 2016; : 196 doi: 10.1002/9781118924938.ch22
|
| 58 |
Tannaz Jamialahmadi, Mohsen Nematy, Ali Jangjoo, Ladan Goshayeshi, Mohammed Altigani Abdalla, Saeed Akhlaghi, Thozhukat Sathyapalan, Amirhossein Sahebkar. The predictive role of parathyroid hormone for non-alcoholic fatty liver disease based on invasive and non-invasive findings in candidates of bariatric surgery. Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity 2022; 27(2): 693 doi: 10.1007/s40519-021-01151-2
|
| 59 |
Zhian Sherzad Hayder, Zrar Saleem Kareem. Resistin hormone in diabetic kidney disease and its relation to iron status and hepcidin. International Urology and Nephrology 2020; 52(4): 749 doi: 10.1007/s11255-020-02434-w
|
| 60 |
Luc F. Van Gaal, Jonathan Mertens, Sven Francque, Christophe De Block. Therapeutic approaches for non-alcoholic steatohepatitis. Therapeutic Advances in Endocrinology and Metabolism 2021; 12 doi: 10.1177/20420188211034300
|
| 61 |
Rohit A. Sinha, Brijesh K. Singh, Paul M. Yen. Thyroid hormone regulation of hepatic lipid and carbohydrate metabolism. Trends in Endocrinology & Metabolism 2014; 25(10): 538 doi: 10.1016/j.tem.2014.07.001
|
| 62 |
Juan Esteban Oyarzún, Marcelo E. Andia, Sergio Uribe, Paula Núñez Pizarro, Gabriel Núñez, Gloria Montenegro, Raquel Bridi. Honeybee Pollen Extracts Reduce Oxidative Stress and Steatosis in Hepatic Cells. Molecules 2020; 26(1): 6 doi: 10.3390/molecules26010006
|
| 63 |
Elmar Aigner, Alexandra Feldman, Christian Datz. Obesity as an Emerging Risk Factor for Iron Deficiency. Nutrients 2014; 6(9): 3587 doi: 10.3390/nu6093587
|
| 64 |
Zhen-Shu Liu, Pei-Lin Li, Yu-We Ku, Po-Wen Chen. Oral Administration of Recombinant Lactoferrin-Expressing Probiotics Ameliorates Diet-Induced Lipid Accumulation and Inflammation in Non-Alcoholic Fatty Liver Disease in Mice. Microorganisms 2022; 10(11): 2215 doi: 10.3390/microorganisms10112215
|
| 65 |
Iria Cebreiros López, Florentina Guzmán Aroca, Maria Dolores Frutos Bernal, Juan Antonio Luján Mompeán, Águeda Bas Bernal, Antonio Miguel Hernández Martínez, Enrique Martínez Barba, Jose Antonio Noguera Velasco, Pascual Parilla Paricio. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease. Obesity Surgery 2017; 27(9): 2347 doi: 10.1007/s11695-017-2606-9
|
| 66 |
Alex M DePaoli. 20 YEARS OF LEPTIN: Leptin in common obesity and associated disorders of metabolism. Journal of Endocrinology 2014; 223(1): T71 doi: 10.1530/JOE-14-0258
|
| 67 |
Minyi Qian, Qianqian Lyu, Yujie Liu, Haiyang Hu, Shilei Wang, Chuyue Pan, Xubin Duan, Yingsheng Gao, Lian-wen Qi, Weizhi Liu, Lirui Wang. Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice. Marine Drugs 2019; 17(7): 391 doi: 10.3390/md17070391
|
| 68 |
Mark L. Dreher. Dietary Patterns and Whole Plant Foods in Aging and Disease. 2018; : 291 doi: 10.1007/978-3-319-59180-3_10
|
| 69 |
Tomohiro Takahashi, Wataru Sugawara, Yuya Takiguchi, Kento Takizawa, Ami Nakabayashi, Mitsuo Nakamura, Michiyo Nagano-Ito, Shinichi Ichikawa, I-Min Liu. Identification of Plants That Inhibit Lipid Droplet Formation in Liver Cells: Rubus suavissimus Leaf Extract Protects Mice from High‐Fat Diet‐Induced Fatty Liver by Directly Affecting Liver Cells. Evidence-Based Complementary and Alternative Medicine 2016; 2016(1) doi: 10.1155/2016/4282758
|
| 70 |
Eun Na Han, Eun Sun Cheong, Jeong In Lee, Min Chul Kim, Christopher D. Byrne, Ki-Chul Sung. Change in fatty liver status and 5-year risk of incident metabolic syndrome: a retrospective cohort study. Clinical Hypertension 2015; 21(1) doi: 10.1186/s40885-015-0032-7
|
| 71 |
Vishal Patel, Amit Joharapurkar, Samadhan Kshirsagar, Maulik Patel, Brijesh Sutariya, Hiren Patel, Dheerendra Pandey, Dipam Patel, Ramchandra Ranvir, Shekhar Kadam, Rajesh Bahekar, Mukul Jain. Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates nonalcoholic fatty liver disease. Canadian Journal of Physiology and Pharmacology 2018; 96(6): 587 doi: 10.1139/cjpp-2017-0683
|
| 72 |
Fariborz Mansour-Ghanaei, Makan Pourmasoumi, Amir Hadi, Farahnaz Joukar. Efficacy of curcumin/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled trials. Integrative Medicine Research 2019; 8(1): 57 doi: 10.1016/j.imr.2018.07.004
|
| 73 |
Dimitrios Papandreou, Eleni Andreou. Role of diet on non-alcoholic fatty liver disease: An updated narrative review. World Journal of Hepatology 2015; 7(3): 575-582 doi: 10.4254/wjh.v7.i3.575
|
| 74 |
Geir Bjørklund, Massimiliano Peana, Lyudmila Pivina, Alexandru Dosa, Jan Aaseth, Yuliya Semenova, Salvatore Chirumbolo, Serenella Medici, Maryam Dadar, Daniel-Ovidiu Costea. Iron Deficiency in Obesity and after Bariatric Surgery. Biomolecules 2021; 11(5): 613 doi: 10.3390/biom11050613
|
| 75 |
Rui-rui Wang, Lin-fang Zhang, Lu-ping Chen, Jian-ying Wang, Lei Zhang, Yue-song Xu, Pei-lin Yang, Guang Ji, Bao-cheng Liu, Raul Dominguez Perles. Structural and Functional Modulation of Gut Microbiota by Jiangzhi Granules during the Amelioration of Nonalcoholic Fatty Liver Disease. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/2234695
|
| 76 |
Shengtao Zhu, Jihong Shi, Chunpeng Ji, Guang Yang, Jie Xing, Feng Zhu, Liming Lin, Aijun Xing, Zhe Huang, Chenrui Zhu, Xiaoming Wei, Shutian Zhang, Junchao Gu, Shouling Wu. Association of the ideal cardiovascular behaviors and factors with the incidence of nonalcoholic fatty liver disease: a prospective study. European Journal of Gastroenterology & Hepatology 2018; 30(5): 578 doi: 10.1097/MEG.0000000000001069
|
| 77 |
YAN-GUI WANG, TIAN-LUN YANG. Liraglutide reduces fatty degeneration in hepatic cells via the AMPK/SREBP1 pathway. Experimental and Therapeutic Medicine 2015; 10(5): 1777 doi: 10.3892/etm.2015.2741
|
| 78 |
Jia Liu, Shan Jiang, Yue Zhao, Qian Sun, Jingzi Zhang, Di Shen, Jing Wu, Ning Shen, Xiao Fu, Xitai Sun, Decai Yu, Jun Chen, Jian He, Tingting Shi, Yitao Ding, Lei Fang, Bin Xue, Chaojun Li. Geranylgeranyl diphosphate synthase (GGPPS) regulates non‐alcoholic fatty liver disease (NAFLD)–fibrosis progression by determining hepatic glucose/fatty acid preference under high‐fat diet conditions. The Journal of Pathology 2018; 246(3): 277 doi: 10.1002/path.5131
|
| 79 |
Neda Azizi, Mohammad Reza Amini, Kurosh Djafarian, Sakineh Shab-Bidar. The Effects of Nigella sativa Supplementation on Liver Enzymes Levels: a Systematic Review and Meta-analysis of Randomized Controlled Trials. Clinical Nutrition Research 2021; 10(1): 72 doi: 10.7762/cnr.2021.10.1.72
|
| 80 |
И.Р. Агабабян, Ш.Ш. Садыкова. Pleyotropic Effects of Statins Non-Alcoholic Fat Disease of the Liver Non-Alcoholic Steatohepatitis. Рецепт 2022; (2): 194 doi: 10.34883/PI.2022.25.2.006
|
| 81 |
Brian Finan, Christoffer Clemmensen, Zhimeng Zhu, Kerstin Stemmer, Karine Gauthier, Luisa Müller, Meri De Angelis, Kristin Moreth, Frauke Neff, Diego Perez-Tilve, Katrin Fischer, Dominik Lutter, Miguel A. Sánchez-Garrido, Peng Liu, Jan Tuckermann, Mohsen Malehmir, Marc E. Healy, Achim Weber, Mathias Heikenwalder, Martin Jastroch, Maximilian Kleinert, Sigrid Jall, Sara Brandt, Frédéric Flamant, Karl-Werner Schramm, Heike Biebermann, Yvonne Döring, Christian Weber, Kirk M. Habegger, Michaela Keuper, Vasily Gelfanov, Fa Liu, Josef Köhrle, Jan Rozman, Helmut Fuchs, Valerie Gailus-Durner, Martin Hrabě de Angelis, Susanna M. Hofmann, Bin Yang, Matthias H. Tschöp, Richard DiMarchi, Timo D. Müller. Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease. Cell 2016; 167(3): 843 doi: 10.1016/j.cell.2016.09.014
|
| 82 |
Yilin Song, Lianzhen Zhou, Michael D. Jensen. Errors in measuring plasma free fatty acid concentrations with a popular enzymatic colorimetric kit. Clinical Biochemistry 2019; 66: 83 doi: 10.1016/j.clinbiochem.2019.01.008
|
| 83 |
Gavin Hamilton, Michael S. Middleton, Elhamy R. Heba, Claude B. Sirlin. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. 2019; : 141 doi: 10.1007/978-3-030-11748-1_6
|
| 84 |
Afagh Garjani, Abdolrasoul Safaeiyan, Manouchehr Khoshbaten. Association Between Platelet Count as a Noninvasive Marker and Ultrasonographic Grading in Patients With Nonalcoholic Fatty Liver Disease. Hepatitis Monthly 2015; 15(1) doi: 10.5812/hepatmon.24449
|
| 85 |
Adam Jurgoński, Bartosz Fotschki, Jerzy Juśkiewicz. Disparate metabolic effects of blackcurrant seed oil in rats fed a basal and obesogenic diet. European Journal of Nutrition 2015; 54(6): 991 doi: 10.1007/s00394-014-0775-z
|
| 86 |
John E. Lewis, Steven E. Atlas, Oscar L. Higuera, Andrea Fiallo, Ammar Rasul, Ashar Farooqi, Olga Kromo, Laura A. Lantigua, Eduard Tiozzo, Judi M. Woolger, Sharon Goldberg, Armando Mendez, Allan E. Rodriguez, Janet Konefal, Hajime Nakae. The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver Disease. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/1751583
|
| 87 |
Pankaj Prabhakar, Vijay Marakala, Dhanya Sacheendran, Thomas George, Rhea Katherine D'souza, Princy Louis Palatty, Manjeshwar Shrinath Baliga. Ginger (Zingiber officinale Roscoe; Family: Zingiberaceae) in Non-Alcoholic Fatty Liver Disease: Review on the Existing Scientific Evidence and Way Forward. Current Nutrition & Food Science 2024; 20(7): 789 doi: 10.2174/1573401319666230913122317
|
| 88 |
Carla Lubrano, Giuseppe Valacchi, Palma Specchia, Lucio Gnessi, Elizaveta P. Rubanenko, Elena A. Shuginina, Arseny I. Trukhanov, Liudmila G. Korkina, Chiara De Luca. Integrated Haematological Profiles of RedoxStatus, Lipid, and Inflammatory Protein Biomarkers in Benign Obesity and Unhealthy Obesity with Metabolic Syndrome. Oxidative Medicine and Cellular Longevity 2015; 2015: 1 doi: 10.1155/2015/490613
|
| 89 |
Yunxia Dong, Henglei Lu, Qiang Li, Xinming Qi, Yuanchao Li, Zean Zhang, Jing Chen, Jin Ren. (5R)-5-hydroxytriptolide ameliorates liver lipid accumulation by suppressing lipid synthesis and promoting lipid oxidation in mice. Life Sciences 2019; 232: 116644 doi: 10.1016/j.lfs.2019.116644
|
| 90 |
|
| 91 |
Aida Abdeen Mahmoud, Asmaa N. Mohammad, Mohamed Abdel Wahab Ezat. Evaluation of Circulating Fatty Acid Synthase as a Biomarker in Non-Alcoholic Fatty Liver Disease. Open Journal of Gastroenterology 2016; 6(09): 229 doi: 10.4236/ojgas.2016.69028
|
| 92 |
Roya Mansour-Ghanaei, Fariborz Mansour-Ghanaei, Mohammadreza Naghipour, Farahnaz Joukar, Zahra Atrkar-Roushan, Mohammadjavad Tabatabaii, Najmeh Ghorani. The role of anthropometric indices in the prediction of non-alcoholic fatty liver disease in the PERSIAN Guilan Cohort study (PGCS). Journal of Medicine and Life 2018; 11(3): 194 doi: 10.25122/jml-2018-0031
|